Key points in migraine prophylaxis: patient perspective.
Migraine is a chronic neurological condition with heterogeneous presentation. It is associated with significant pain, disability, and diminished quality of life in a large proportion of patients. Patients with severe and/or frequent migraines require prophylaxis, which implies daily administration of anti-migraine compounds for several months, with potential adverse events or contraindications. This paper reviews the main factors influencing patient acceptance of anti-migraine prophylaxis, providing practical suggestions to maximize patient agreement with, and adherence to, preventive treatment.
Headache Centre, Department of Neurological Sciences, C. Besta Neurological Institute, Via Celoria 11, 20133, Milan, Italy. damicodo@tiscali.it
Domenico
D
D'Amico
S J
SJ
Tepper
D002491:Central Nervous System Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000517:prevention & control*; D010342:Patient Acceptance of Health Care; D013997:Time Factors
D002491:Central Nervous System Agents